VYNE Therapeutics Announces Reverse Stock Split and Merger Update
VYNE Therapeutics Inc. announced a 1-for-50 reverse stock split and provided an update regarding a special dividend in connection with its proposed merger with Yarrow Bioscience.
Want more?
Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.